Cargando…

Identification of RRAS gene related to nasopharyngeal carcinoma based on pathway and network-based analyses

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a highly aggressive neoplasm mainly distributed in the eastern and southeastern parts of Asia. NPC has a poor prognosis among head and neck cancers, and molecular-targeted therapies showed limited clinical efficacy. METHODS: We reviewed publications in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Ruowen, Shi, Lu, Yang, Te, Zhang, Meiyin, Wang, Huiyun, Mai, Shijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798477/ https://www.ncbi.nlm.nih.gov/pubmed/35116799 http://dx.doi.org/10.21037/tcr.2019.04.04

Ejemplares similares

Response to the hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-barr virus?
por: Xiao, Ruowen, et al.
Publicado: (2019)

MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma
por: Mai, ShiJuan, et al.
Publicado: (2019)

The Hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?
por: Tan, Mark T. L., et al.
Publicado: (2019)

RRas2, RhoG and T-cell phagocytosis
por: Alarcón, Balbino, et al.
Publicado: (2012)

RRAS2 shapes the TCR repertoire by setting the threshold for negative selection
por: Martínez-Riaño, Ana, et al.
Publicado: (2019)

STRESS granule-associated RNA-binding protein CAPRIN1 drives cancer progression and regulates treatment response in nasopharyngeal carcinoma
por: Yang, Te, et al.
Publicado: (2022)

In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies
por: van Engelen, Nienke, et al.
Publicado: (2022)

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
por: Flex, Elisabetta, et al.
Publicado: (2014)

Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
por: Hortal, Alejandro M., et al.
Publicado: (2022)

Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS
por: Perrot, Carole Y., et al.
Publicado: (2018)

Transfection of Sponge Cells and Intracellular Localization of Cancer-Related MYC, RRAS2, and DRG1 Proteins
por: Dominko, Kristina, et al.
Publicado: (2023)

A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington's Disease
por: Miller, John P., et al.
Publicado: (2012)

METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS
por: Chen, Jie-Xun, et al.
Publicado: (2023)

Omics-Based Identification of Biomarkers for Nasopharyngeal Carcinoma
por: Janvilisri, Tavan
Publicado: (2015)

Transcriptomic Analyses Reveal Gene Expression Profiles and Networks in Nasopharyngeal Carcinoma
por: Zhou, Yaqi, et al.
Publicado: (2021)

Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis
por: Chen, Fang, et al.
Publicado: (2017)

Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis
por: Song, Yujie, et al.
Publicado: (2022)

An Optimized Single Nucleotide Polymorphism-Based Detection Method Suggests That Allelic Variants in the 3’ Untranslated Region of RRAS2 Correlate with Treatment Response in Chronic Lymphocytic Leukemia Patients
por: Hortal, Alejandro, et al.
Publicado: (2023)

Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking
por: Fan, Jing-Ying, et al.
Publicado: (2023)

Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis
por: Zhang, Xiujuan, et al.
Publicado: (2021)

BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathway
por: Wang, Meng-He, et al.
Publicado: (2017)

Identification of key genes involved in nasopharyngeal carcinoma()
por: Jiang, Xue, et al.
Publicado: (2016)

Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
por: Kang, Yuanbo, et al.
Publicado: (2020)

Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis
por: Xue, Kai, et al.
Publicado: (2019)

Successful Identification of Nasopharyngeal Carcinoma in Nasopharyngeal Biopsies Using Deep Learning
por: Chuang, Wen-Yu, et al.
Publicado: (2020)

Emerging treatment options for nasopharyngeal carcinoma
por: Zhang, Lu, et al.
Publicado: (2013)

Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
por: Kang, Yuanbo, et al.
Publicado: (2020)

Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma
por: Wen, Wen, et al.
Publicado: (2019)

Network and pathway-based analyses of genes associated with osteoporosis
por: Gu, Huijie, et al.
Publicado: (2020)

Comparison of radiomics tools for image analyses and clinical prediction in nasopharyngeal carcinoma
por: Liang, Zhong-Guo, et al.
Publicado: (2019)

Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma
por: Wu, Chun, et al.
Publicado: (2022)

Clinical and prognostic analyses of 110 patients with N(3) nasopharyngeal carcinoma
por: Chen, Jing, et al.
Publicado: (2018)

Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research
por: Zhang, Pei-Fen, et al.
Publicado: (2018)

Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy
por: Liu, Jun, et al.
Publicado: (2016)

Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening
por: Chen, Yufeng, et al.
Publicado: (2015)

Pathway-based analyses
por: Kent, Jack W.
Publicado: (2016)

Molecular Assessment of Scutellaria barbata D. Don in the Treatment of Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Verification
por: Shi, Hongjian, et al.
Publicado: (2022)

The Efficacy and Safety of Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Nasopharyngeal Carcinoma: Literature-based Meta-analyses
por: Peng, Liang, et al.
Publicado: (2018)

MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2
por: Yang, Huiyun, et al.
Publicado: (2022)

Deep Learning for Predicting Distant Metastasis in Patients with Nasopharyngeal Carcinoma Based on Pre-Radiotherapy Magnetic Resonance Imaging
por: Hua, Hong-Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_40o2toak20u81s8ohlfgtbavfq